Infinity Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Infinity Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 40% to $2,593,000. The net income raised on -$43,256,000 and profit margin reached -1668%. Total operating expenses were $45,874,000.
Profit Margin
| 2013 | 0 | -126.78M | |
|---|---|---|---|
| 2014 | 164.99M | -17.41M | -10.56% |
| 2015 | 109.06M | -128.37M | -117.7% |
| 2016 | 18.72M | -30.10M | -160.77% |
| 2017 | 6M | -41.83M | -697.17% |
| 2018 | 22.14M | -11.25M | -50.81% |
| 2019 | 3.04M | -47.05M | -1543.36% |
| 2020 | 1.71M | -42.93M | -2497.79% |
| 2021 | 1.85M | -45.44M | -2445.75% |
| 2022 | 2.59M | -43.25M | -1668.18% |
INFI Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.59M | 1.85M | 1.71M | 3.04M | 22.14M | 6M | 18.72M | 109.06M | 164.99M | 0 |
Cost of revenue | 1.56M | 1.12M | 1.03M | 7.30M | 69K | 0 | 0 | 0 | 0 | 0 |
Gross profit | 1.03M | 738K | 682K | -4.25M | 22.07M | 6M | 18.72M | 109.06M | 164.99M | 0 |
Operating exp. | ||||||||||
Research and development | 32.41M | 31.64M | 26.76M | 27.11M | 19.75M | 20.83M | 119.61M | 199.10M | 143.63M | 99.76M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 45.87M | 45.82M | 39.17M | 41.40M | 34.00M | 42.44M | 161.83M | 236.17M | 172.91M | 127.67M |
Operating income | -44.84M | -45.08M | -38.49M | -45.66M | -11.92M | -36.44M | -30.89M | -127.10M | -7.92M | -127.67M |
Other income (expenses), net | 475K | -179K | -1.99M | -1.44M | 769K | -6.10M | 114.23M | -933K | -9.31M | 896K |
Income before tax | -44.36M | -45.26M | -40.49M | -47.11M | -11.25M | -42.55M | -30.10M | -128.04M | -17.23M | -126.78M |
Income tax expense | -1.11M | 180K | 2.44M | -54K | 769K | -720K | -2.19M | 335K | 183K | 0 |
Net income | -43.25M | -45.44M | -42.93M | -47.05M | -11.25M | -41.83M | -30.10M | -128.37M | -17.41M | -126.78M |
Earnings per share | ||||||||||
Basic EPS | -0.48 | -0.53 | -0.72 | -0.83 | -0.2 | -0.83 | -0.61 | -2.62 | -0.36 | -2.64 |
Diluted EPS | -0.48 | -0.53 | -0.72 | -0.83 | -0.2 | -0.83 | -0.61 | -2.62 | -0.36 | -2.64 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |